Pages that link to "Q34786549"
Jump to navigation
Jump to search
The following pages link to Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. (Q34786549):
Displaying 50 items.
- Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen (Q21328680) (← links)
- Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Q24201328) (← links)
- Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses (Q26777948) (← links)
- Clinical implications of enteroadherent Escherichia coli (Q26865925) (← links)
- New Developments in Traveler's Diarrhea (Q28387036) (← links)
- Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch. (Q30383418) (← links)
- Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods (Q30409328) (← links)
- New technologies for influenza vaccines (Q30411859) (← links)
- Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies (Q30427618) (← links)
- Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin (Q33503623) (← links)
- Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea (Q33825679) (← links)
- Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine (Q33928456) (← links)
- Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy (Q34009407) (← links)
- Langerhans cells as targets for immunotherapy against skin cancer. (Q34009436) (← links)
- Laser vaccine adjuvant for cutaneous immunization (Q34046148) (← links)
- Recent advances in understanding enteric pathogenic Escherichia coli. (Q34375210) (← links)
- High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants (Q34466125) (← links)
- Vaccines against enterotoxigenic Escherichia coli (Q34594874) (← links)
- Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology (Q34685461) (← links)
- Expert review of the evidence base for prevention of travelers' diarrhea (Q34987670) (← links)
- Delivery Systems for Intradermal Vaccination (Q35214379) (← links)
- A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phas (Q35598235) (← links)
- Therapeutic Transcutaneous Immunization with a Band-Aid Vaccine Resolves Experimental Otitis Media (Q35901982) (← links)
- An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli (Q35944776) (← links)
- Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea (Q35998767) (← links)
- CONSORT 2010 statement: extension to randomised pilot and feasibility trials (Q36173563) (← links)
- Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation. (Q36258425) (← links)
- The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease (Q36505159) (← links)
- New routes for allergen immunotherapy (Q36864957) (← links)
- Paediatric travel medicine: vaccines and medications (Q36948104) (← links)
- Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook (Q37316009) (← links)
- Vaccine adjuvants: scientific challenges and strategic initiatives (Q37403484) (← links)
- Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant (Q37441681) (← links)
- Particle based vaccine formulations for transcutaneous immunization (Q37530378) (← links)
- Prophylaxis for travelers' diarrhea (Q37554879) (← links)
- Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination. (Q37561165) (← links)
- Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines (Q37593785) (← links)
- Travellers' diarrhoea - pros and cons of different prophylactic measures (Q37633392) (← links)
- Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines. (Q37634138) (← links)
- Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials (Q37786494) (← links)
- Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? (Q37792508) (← links)
- Towards a Chlamydia trachomatis vaccine: how close are we? (Q37820669) (← links)
- Targeting skin dendritic cells to improve intradermal vaccination. (Q37831193) (← links)
- Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections (Q37854439) (← links)
- Defending the mucosa: adjuvant and carrier formulations for mucosal immunity (Q37867814) (← links)
- Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? (Q37868794) (← links)
- Novel Administration Routes for Allergen-Specific Immunotherapy: A Review of Intralymphatic and Epicutaneous Allergen-Specific Immunotherapy (Q37870456) (← links)
- A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC) (Q37880347) (← links)
- A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression (Q37896946) (← links)
- The epidermis as an adjuvant (Q37973179) (← links)